![Michael Berry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Berry
Chief Tech/Sci/R&D Officer at
EVEREST MEDICINES LIMITED
Profile
Michael Berry is currently the Chief Technology Officer at Everest Medicines Ltd. He previously worked as the Senior Director of Bioprocess Development at Portola Pharmaceuticals, Director at ARCA biopharma, Director of Manufacturing Sciences & Technology at Novartis Vaccines & Diagnostics SL, and Vice President at Dynavax Technologies Corp.
He is also the Chief Technical Operations Officer at Clover Biopharmaceuticals Ltd. Berry received his undergraduate degree from De Montfort University, his graduate degree from The University of Manchester, and his doctorate from the University of Manitoba.
Michael Berry active positions
| Companies | Position | Start |
|---|---|---|
| EVEREST MEDICINES LIMITED | Chief Tech/Sci/R&D Officer | 14/06/2023 |
Former positions of Michael Berry
| Companies | Position | End |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 31/07/2017 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/01/2015 |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | 31/08/2013 |
| ARCA BIOPHARMA | Director/Board Member | 30/04/2009 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | - |
Training of Michael Berry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
De Montfort University
 De Montfort University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Novartis Vaccines & Diagnostics SL | |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Michael Berry
